The AT
1 receptor is a G-protein-coupled receptor (GPCR); its activation from the basal state(R) requires an interaction between Asn
111 in transmembrane helix III (TM-III) of the receptor and theTyr
4 residue of angiotensin II (Ang II). Asn
111 to Gly
111 mutation (N111G) results in constitutive activationof the AT
1 receptor (Noda et al. (1996)
Biochemistry,
35, 16435-16442). We show here that replacementof the AT
1 receptors TM-III with a topologically identical 16-residue segment (Cys
101-Val
116) from theAT
2 receptor induces constitutive activity, although Asn
111 is preserved in the resulting chimera, CR18.Effects of CR18 and N111G mutations are neither additive nor synergistic. The conformation(s) inducedin either mutant mimics the partially activated state (R'), and transition to the fully activated R* conformationin both no longer requires the Tyr
4 of Ang II. Both the R state of the receptor and the Tyr
4 Ang IIdependence of receptor activation can be reinstated by introduction of a larger sized Phe side chain at t
he111 position in CR18, suggesting that the CR18 mutation generated an effect similar to the reduction ofside chain size in the N111G mutation. Consistently in the native AT
1 receptor, R' conformation isgenerated by replacement with residues smaller but not larger than the Asn
111. However, size substitutionof several other TM-III residues in both receptors did not affect transitions between R, R', and R* states.Thus, the property responsible for Asn
111 function as a conformational switch is neither polarity norhydrogen bonding potential but the side chain size. We conclude that the fundamental mechanismresponsible for constitutive activation of the AT
1 receptor is to increase the entropy of the key agonist-switch binding residue, Asn
111. As a result, the normally agonist-dependent R
R' transition occursspontaneously. This mechanism may be applicable to many other GPCRs.